We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    tisherman
Previous Study | Return to List | Next Study

Emergency Preservation and Resuscitation (EPR) for Cardiac Arrest From Trauma (EPR-CAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01042015
Recruitment Status : Recruiting
First Posted : January 5, 2010
Last Update Posted : December 13, 2022
John H. Stroger Hospital
Information provided by (Responsible Party):
Samuel Tisherman, University of Maryland, Baltimore

Brief Summary:
The goal of this study is to rapidly cool trauma victims who have suffered cardiac arrest from bleeding with a flush of ice-cold sodium chloride to preserve the patient to enable surgical control of bleeding, followed by delayed resuscitation with cardiopulmonary bypass.

Condition or disease Intervention/treatment Phase
Cardiac Arrest From Trauma Combination Product: Emergency preservation and resuscitation Other: Standard resuscitation Phase 2

Detailed Description:

The intent of the technique to be studied is to induce a state of hypothermic preservation in trauma victims who have exsanguinated to the point of cardiac arrest. In appropriately selected subjects, after an initial emergency attempt at resuscitation with standard techniques, an arterial catheter will be inserted into the descending thoracic aorta. Using appropriate tubing, pump, and heat exchanger,a large quantity of ice-cold saline (0.9% Sodium Chloride for Injection USP) will be pumped as rapidly as possible into the aorta with the goal of cooling the brain (tympanic membrane temperature, Tty) to <10 C. If possible, a large venous catheter will be placed and recirculation of fluid established.

Once the subject has been sufficiently cooled, bleeding will be controlled surgically. The subject will then be resuscitated and rewarmed with full cardiopulmonary bypass.

The goal is to improve neurologically-intact survival in these patients.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Emergency Preservation and Resuscitation for Cardiac Arrest From Trauma
Actual Study Start Date : October 2016
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : December 2023

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: Concurrent controls
These subjects would undergo standard resuscitative efforts.
Other: Standard resuscitation
Standard resuscitation includes an emergency department thoracotomy, open cardiac massage, and fluid resuscitation.

Experimental: Emergency preservation and resuscitation
These subjects would undergo the complete EPR protocol, including rapid induction of hypothermia, resuscitative surgery, and resuscitation with cardiopulmonary bypass.
Combination Product: Emergency preservation and resuscitation
This involves the induction of profound hypothermia using a flush of ice-cold saline into the aorta. Once hypothermia is achieved, the subject would undergo rapid operative interventions to control bleeding followed by resuscitation/rewarming with cardiopulmonary bypass.

Primary Outcome Measures :
  1. The primary endpoint is survival to hospital discharge without major disability (Glasgow Outcome Scale-Extended >5). [ Time Frame: Hospital discharge ]

Secondary Outcome Measures :
  1. Feasibility of initiating EPR (cooling and achieving goal brain temperature) [ Time Frame: 1 hour ]
  2. Survival [ Time Frame: 28 days ]
  3. Neurologic functional outcome [ Time Frame: 12 months ]
  4. Multiple organ system dysfunction [ Time Frame: During the initial hospitalization ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Penetrating trauma with clinical suspicion of exsanguinating hemorrhage
  • At least 1 sign of life at the scene (pulse, respiratory efforts, spontaneous movements, reactive pupils)
  • Loss of pulse <5 min prior to Emergency Department (ED) arrival or in ED or operating room
  • ED thoracotomy performed without immediate return of a palpable pulse in the carotid arteries after clamping the descending thoracic aorta

Exclusion Criteria:

  • No signs of life for >5 min prior to the decision to initiate EPR
  • Obvious non-survivable injury
  • Suggestion of traumatic brain injury, such as significant facial or cranial distortion
  • Electrical asystole
  • Rapid external assessment of the injuries suggests massive tissue trauma or blunt trauma involving multiple body regions
  • Pregnancy
  • Prisoners

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01042015

Layout table for location contacts
Contact: Samuel A Tisherman, MD 410-328-9781 stisherman@som.umaryland.edu
Contact: Leslie Sult 410-299-3738 lsult@som.umaryland.edu

Layout table for location information
United States, Illinois
Stroger Hospital of Cook County Not yet recruiting
Chicago, Illinois, United States, 60612
Contact: Faran Bokhari, MD    312-864-2741    fbokhari2000@yahoo.com   
United States, Maryland
University of Maryland Recruiting
Baltimore, Maryland, United States, 21201
Contact: Samuel A Tisherman, MD    410-328-9781    stisherman@som.umaryland.edu   
Contact: Leslie Sult, RN    410-328-0288    lsult@som.umaryland.edu   
Sub-Investigator: Thomas Scalea, MD         
Sub-Investigator: James O'Connor, MD         
Sub-Investigator: Joseph Rabin, MD         
Principal Investigator: Samuel A Tisherman, MD         
Sub-Investigator: Kristopher Deatrick, MD         
Sub-Investigator: David Efron, MD         
Sub-Investigator: Rishi Kundi, MD         
Sponsors and Collaborators
University of Maryland, Baltimore
John H. Stroger Hospital
Layout table for investigator information
Principal Investigator: Samuel A Tisherman, MD University of Maryland, Baltimore
  Study Documents (Full-Text)

Documents provided by Samuel Tisherman, University of Maryland, Baltimore:
Study Protocol  [PDF] April 26, 2016

Layout table for additonal information
Responsible Party: Samuel Tisherman, Professor of Surgery, University of Maryland, Baltimore
ClinicalTrials.gov Identifier: NCT01042015    
Other Study ID Numbers: HP-00062740
First Posted: January 5, 2010    Key Record Dates
Last Update Posted: December 13, 2022
Last Verified: December 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: Yes
Keywords provided by Samuel Tisherman, University of Maryland, Baltimore:
cardiac arrest
hemorrhagic shock
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Arrest
Wounds and Injuries
Disease Attributes
Pathologic Processes
Heart Diseases
Cardiovascular Diseases